Kenneth E Palmer Selected Research

Griffithsia griffithsin protein

10/2020	Sustained-release Griffithsin nanoparticle-fiber composites against HIV-1 and HSV-2 infections.
1/2020	Rapid-Release Griffithsin Fibers for Dual Prevention of HSV-2 and HIV-1 Infections.
12/2016	Pharmacokinetics of the Antiviral Lectin Griffithsin Administered by Different Routes Indicates Multiple Potential Uses.
11/2016	Griffithsin-Modified Electrospun Fibers as a Delivery Scaffold To Prevent HIV Infection.
1/2016	Middle East respiratory syndrome coronavirus infection is inhibited by griffithsin.
6/2013	Griffithsin protects mice from genital herpes by preventing cell-to-cell spread.
11/2011	Griffithsin has antiviral activity against hepatitis C virus.
3/2010	Broad-spectrum in vitro activity and in vivo efficacy of the antiviral protein griffithsin against emerging viruses of the family Coronaviridae.
7/2006	Domain-swapped structure of the potent antiviral protein griffithsin and its mode of carbohydrate binding.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kenneth E Palmer Research Topics

Disease

15	Infections 02/2022 - 06/2006
3	Papillomavirus Infections 11/2011 - 06/2006
3	Neoplasms (Cancer) 02/2008 - 09/2006
2	COVID-19 11/2021 - 01/2021
2	Pneumonia (Pneumonitis) 01/2021 - 01/2021
2	Sexually Transmitted Diseases (Sexually Transmitted Disease) 01/2020 - 11/2016
1	Candidiasis (Moniliasis) 10/2021
1	Mycoses (Diseases, Fungus) 10/2021
1	Hepatitis B 01/2019
1	Inflammation (Inflammations) 01/2018
1	Herpes Simplex 12/2016
1	HIV Infections (HIV Infection) 11/2016
1	Virus Diseases (Viral Diseases) 01/2014
1	Herpes Genitalis (Genital Herpes) 06/2013
1	Reinfection 11/2011
1	Chronic Disease (Chronic Diseases) 01/2011
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 06/2009
1	Experimental Melanoma 09/2006
1	Melanoma (Melanoma, Malignant) 09/2006
1	Severe Acute Respiratory Syndrome 07/2006

Drug/Important Bio-Agent (IBA)

10	Antiviral Agents (Antivirals)IBA 10/2021 - 03/2010
9	Griffithsia griffithsin proteinIBA 10/2020 - 07/2006
8	VaccinesIBA 01/2019 - 06/2006
5	Proteins (Proteins, Gene)FDA Link 10/2021 - 09/2006
4	LectinsIBA 10/2020 - 11/2011
2	CytokinesIBA 11/2021 - 10/2020
2	Pharmaceutical PreparationsIBA 10/2021 - 01/2011
2	q-griffithsinIBA 10/2021 - 01/2021
2	Biological ProductsIBA 01/2020 - 11/2016
2	Recombinant ProteinsIBA 01/2019 - 01/2011
2	Neutralizing AntibodiesIBA 06/2009 - 06/2006
2	AntigensIBA 09/2006 - 09/2006
2	Peptides (Polypeptides)IBA 09/2006 - 09/2006
2	EpitopesIBA 09/2006 - 06/2006
1	CannabidiolIBA 02/2022
1	masitinibIBA 01/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	InterferonsIBA 01/2021
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 01/2020
1	Povidone (Crospovidone)IBA 01/2020
1	Polyvinyl AlcoholIBA 01/2020
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2019
1	Immunoglobulins (Immunoglobulin)IBA 01/2019
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 11/2011
1	OligosaccharidesIBA 11/2011
1	Mannose (D-Mannose)IBA 11/2011
1	Drug CombinationsIBA 09/2011
1	Protein Subunit VaccinesIBA 01/2011
1	Synthetic Vaccines (Recombinant Vaccines)IBA 06/2009
1	Anti-Infective Agents (Microbicides)IBA 04/2009
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 09/2006
1	Interferon-gamma (Interferon, gamma)IBA 09/2006
1	peptide SVYDFFVWLIBA 09/2006
1	Monophenol Monooxygenase (Tyrosinase)IBA 09/2006
1	AutoantigensIBA 09/2006
1	Combined VaccinesIBA 09/2006
1	OvalbuminIBA 09/2006

Therapy/Procedure

1	Therapeutics 12/2016
1	Liver Transplantation 11/2011